Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FeelGood vs NuuVim

By GLP-1 ScorecardUpdated

FeelGoodFactor scores not reassessed.
Site position #136

Lower score

NuuVimFactor scores not reassessed.
Site position #113

Higher score

Score comparison

NuuVim has the higher recorded score — 70.6/100 to 69.5/100, but only just.

NuuVim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound. FeelGood is close behind and may still be the better fit — see the factor split below.

Before you choose

Before comparing the headline prices, the FeelGood review and the NuuVim review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, FeelGood vs PreventiveMD and Fitness RX vs NuuVim compare each of them with another graded program, and the list of alternatives to FeelGood ranks the programs closest to FeelGood on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNuuVim +8
80
88
Dose & formulationNuuVim +32
64
96
Clinical oversightFeelGood +25
79
54
Labs & monitoringFeelGood +3
53
50
FulfillmentFeelGood +10
71
61
Contract termsFeelGood +8
55
47
FeelGood · top barNuuVim · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFeelGoodNuuVim
WeighScore69.5/10070.6/100
GradeCC
Site position#136#113
Semaglutide$89/mo month-to-month on a promotional landing page (homepage says injections from $149/mo; compounded)$79/mo (all doses, 3-mo plan, new patients only, compounded)
Tirzepatide$149/mo month-to-month on a promotional landing page (compounded)$133/mo (all doses, 3-mo plan, new patients only, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
FeelGood

Site position #136 · C

Factor scores not reassessed.

Strengths

  • Both compounded semaglutide (GLP-1) and tirzepatide (GLP-1 + GIP) formulations available
  • Low compounded injection entry price ($149/mo) with no membership or hidden fees
  • Oral/dissolvable tablet option for needle-averse patients
  • LegitScript-certified site (seal #247923); OpenLoop Health telehealth backbone
  • Free shipping and HSA/FSA eligibility

What to consider

  • State availability not publicly disclosed on the site
  • Compounding pharmacy partner not named publicly ("US-certified pharmacy" only)
  • Brand-name ("Original") injections are expensive at $1,999/mo and limited in availability
NuuVim

Site position #113 · C

Factor scores not reassessed.

Strengths

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

What to consider

  • There is no month-to-month plan: every rate is billed as one three-month payment
  • The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
  • The site's own llms.txt advertises pricing, FAQ and terms files that all 404
  • No state count is published

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard